125 related articles for article (PubMed ID: 37264702)
1. Reply: Consensus subtypes of HCC associated with clinical outcomes and genomic phenotypes.
Yim SY; Lee JS
Hepatology; 2023 Aug; 78(2):E44. PubMed ID: 37264702
[No Abstract] [Full Text] [Related]
2. Letter to the Editor: Consensus subtypes of HCC associated with clinical outcomes and genomic phenotypes.
Awan MZUA
Hepatology; 2023 Aug; 78(2):E43. PubMed ID: 37246465
[No Abstract] [Full Text] [Related]
3. Consensus subtypes of hepatocellular carcinoma associated with clinical outcomes and genomic phenotypes.
Lee SH; Yim SY; Jeong YS; Li QX; Kang SH; Sohn BH; Kumar SV; Shin JH; Choi YR; Shim JJ; Kim H; Kim JH; Kim S; Guo S; Johnson RL; Kaseb A; Kang KJ; Chun YS; Jang HJ; Lee BG; Woo HG; Ha MJ; Akbani R; Roberts LR; Wheeler DA; Lee JS
Hepatology; 2022 Dec; 76(6):1634-1648. PubMed ID: 35349735
[TBL] [Abstract][Full Text] [Related]
4. Comparative and integrative functional genomics of HCC.
Lee JS; Thorgeirsson SS
Oncogene; 2006 Jun; 25(27):3801-9. PubMed ID: 16799621
[TBL] [Abstract][Full Text] [Related]
5. A novel immune classification reveals distinct immune escape mechanism and genomic alterations: implications for immunotherapy in hepatocellular carcinoma.
Liu Z; Zhang Y; Shi C; Zhou X; Xu K; Jiao D; Sun Z; Han X
J Transl Med; 2021 Jan; 19(1):5. PubMed ID: 33407585
[TBL] [Abstract][Full Text] [Related]
6. Genomic Profiling of Combined Hepatocellular Cholangiocarcinoma Reveals Genomics Similar to Either Hepatocellular Carcinoma or Cholangiocarcinoma.
Murugesan K; Sharaf R; Montesion M; Moore JA; Pao J; Pavlick DC; Frampton GM; Upadhyay VA; Alexander BM; Miller VA; Javle MM; Bekaii Saab TS; Albacker LA; Ross JS; Ali SM
JCO Precis Oncol; 2021 Aug; 5():. PubMed ID: 34476330
[TBL] [Abstract][Full Text] [Related]
7. Integrative Genomic Analysis Identifies the Core Transcriptional Hallmarks of Human Hepatocellular Carcinoma.
Allain C; Angenard G; Clément B; Coulouarn C
Cancer Res; 2016 Nov; 76(21):6374-6381. PubMed ID: 27634755
[TBL] [Abstract][Full Text] [Related]
8. Reply to: "TERT promoter mutation during development of hepatoblastoma to hepatocellular carcinoma".
Kappler R; Leuschner I; von Schweinitz D
J Hepatol; 2015 Feb; 62(2):498-9. PubMed ID: 25450207
[No Abstract] [Full Text] [Related]
9. Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification.
Calderaro J; Couchy G; Imbeaud S; Amaddeo G; Letouzé E; Blanc JF; Laurent C; Hajji Y; Azoulay D; Bioulac-Sage P; Nault JC; Zucman-Rossi J
J Hepatol; 2017 Oct; 67(4):727-738. PubMed ID: 28532995
[TBL] [Abstract][Full Text] [Related]
10. Integrating Genomics Into Clinical Practice in Hepatocellular Carcinoma: The Challenges Ahead.
Pillai A; Ahn J; Kulik L
Am J Gastroenterol; 2020 Dec; 115(12):1960-1969. PubMed ID: 33038134
[TBL] [Abstract][Full Text] [Related]
11. Genomic decoding of hepatocellular carcinoma.
Thorgeirsson SS
Gastroenterology; 2006 Oct; 131(4):1344-6. PubMed ID: 17030203
[No Abstract] [Full Text] [Related]
12. Challenges of incorporating gene expression data to predict HCC prognosis in the age of systems biology.
Du Y; Cao GW
World J Gastroenterol; 2012 Aug; 18(30):3941-4. PubMed ID: 22912544
[TBL] [Abstract][Full Text] [Related]
13. Common Molecular Subtypes Among Asian Hepatocellular Carcinoma and Cholangiocarcinoma.
Chaisaingmongkol J; Budhu A; Dang H; Rabibhadana S; Pupacdi B; Kwon SM; Forgues M; Pomyen Y; Bhudhisawasdi V; Lertprasertsuke N; Chotirosniramit A; Pairojkul C; Auewarakul CU; Sricharunrat T; Phornphutkul K; Sangrajrang S; Cam M; He P; Hewitt SM; Ylaya K; Wu X; Andersen JB; Thorgeirsson SS; Waterfall JJ; Zhu YJ; Walling J; Stevenson HS; Edelman D; Meltzer PS; Loffredo CA; Hama N; Shibata T; Wiltrout RH; Harris CC; Mahidol C; Ruchirawat M; Wang XW;
Cancer Cell; 2017 Jul; 32(1):57-70.e3. PubMed ID: 28648284
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive genomic signature of pyroptosis-related genes and relevant characterization in hepatocellular carcinoma.
Wang S; Gao S; Shan L; Qian X; Luan J; Lv X
PeerJ; 2023; 11():e14691. PubMed ID: 36650832
[TBL] [Abstract][Full Text] [Related]
15. [Genomic prognostic markers in hepatocellular carcinoma].
Alsinet C; Villanueva A
Gastroenterol Hepatol; 2012 Feb; 35(2):94-101. PubMed ID: 22178501
[TBL] [Abstract][Full Text] [Related]
16. Integrated Genomic Comparison of Mouse Models Reveals Their Clinical Resemblance to Human Liver Cancer.
Yim SY; Shim JJ; Shin JH; Jeong YS; Kang SH; Kim SB; Eun YG; Lee DJ; Conner EA; Factor VM; Moore DD; Johnson RL; Thorgeirsson SS; Lee JS
Mol Cancer Res; 2018 Nov; 16(11):1713-1723. PubMed ID: 30082483
[TBL] [Abstract][Full Text] [Related]
17. A genomic case study of mixed fibrolamellar hepatocellular carcinoma.
Griffith OL; Griffith M; Krysiak K; Magrini V; Ramu A; Skidmore ZL; Kunisaki J; Austin R; McGrath S; Zhang J; Demeter R; Graves T; Eldred JM; Walker J; Larson DE; Maher CA; Lin Y; Chapman W; Mahadevan A; Miksad R; Nasser I; Hanto DW; Mardis ER
Ann Oncol; 2016 Jun; 27(6):1148-1154. PubMed ID: 27029710
[TBL] [Abstract][Full Text] [Related]
18. Genomic and transcriptomic somatic alterations of hepatocellular carcinoma in non-cirrhotic livers.
Skidmore ZL; Kunisaki J; Lin Y; Cotto KC; Barnell EK; Hundal J; Krysiak K; Magrini V; Trani L; Walker JR; Fulton R; Brunt EM; Miller CA; Wilson RK; Mardis ER; Griffith M; Chapman W; Griffith OL
Cancer Genet; 2022 Jun; 264-265():90-99. PubMed ID: 35568002
[TBL] [Abstract][Full Text] [Related]
19. Clinical and genomic landscape of hepatocellular carcinoma subtypes with various proportions of nonleukocyte stromal cells.
Peng J; Li C; Zhou J; Peng J; Wang C; Lai S; Guo S; Zhong Y; Deng L; Tang X
Gene; 2020 Nov; 761():145028. PubMed ID: 32763490
[TBL] [Abstract][Full Text] [Related]
20. Integration of genomic information in the clinical management of HCC.
Quetglas IM; Moeini A; Pinyol R; Llovet JM
Best Pract Res Clin Gastroenterol; 2014 Oct; 28(5):831-42. PubMed ID: 25260311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
